DCC PLC (LSE:DCC) moved to the top of the FTSE 100 after broker Jefferies said that splitting off its energy arm might generate 40% upside.
After talking to management “We are increasingly confident that the move to simplify the group will unlock embedded value,” said the US bank.
Morrisons is slowly digging itself out of the debt hole dug for it via the highly leveraged takeover by US private equity fund Clayton, Dubilier & Rice (CD&R), says Shore Capital.
That overleverage led Morrisons to dispose of its lucrative fuel activities to the private equity firm’s co-owned Motor Fuel Group and to explore selective store disposals, most of which are freehold, adds the broker.
Rio Tinto Ltd's (LSE:RIO, ASX:RIO, OTC:RTNTF) SimFer mine in Simandou, Guinea, appears increasingly unlikely to meet its 2025 first production target, according to satellite image analysis by experts at UBS.
The ambitious project, which includes a mine, a 630-kilometre railway, and a port, is facing growing risks of delays due to incomplete construction, a recent fatality, extreme rainfall, and political uncertainty in Guinea.
UK housebuilders' stock market valuations are lower now than at the start of the year, though trading conditions are "more robust", analysts at broker Jefferies reckon.
They noted that shares are on average now trading below the net tangible asset value (P/NTAV) and were back to below pre-election levels, even though earnings per share forecasts are more than 10% higher.
Imperial Brands PLC (LSE:IMB) shares are trading at five-year highs in a clear sign that the tobacco giant’s strategy of delivering substantial cash returns to shareholders while transitioning to next-generation products (NGPs) is paying off.
The maker of Lambert & Butler and Gauloises cigarettes, Golden Virginia and Drum tobacco, and Blu vapes confirmed a 4.5% hike to its dividend in today’s annual results and set out guidance for the new financial year.
Water companies might get some leeway in Ofwat’s final determination in December, according to analysts at Jefferies after meeting with officials from the
Data on outcome delivery incentives (ODIs) is helping to give a greater understanding of sector performance, said the US bank, which Jefferies believes might mean a more balanced ODI framework at final determinations.
The mRNA (messenger RNA) technology that powered the rapid development of COVID-19 vaccines is now driving a broader revolution in medicine.
According to Berenberg, this innovative approach has the potential to transform the treatment of multiple ailments, particularly cancer and infectious diseases.
In its latest outlook for 2025, Goldman Sachs is urging investors to “buy British” as undervalued UK stocks offer an attractive opportunity in Europe’s otherwise tepid equity market.
The bank highlights that UK shares, particularly those with a domestic focus, are trading at a discount compared to other European and US markets.
As the United States moves into 2025 with Donald Trump back in the White House, Goldman Sachs has outlined a positive outlook for the year, drawing on the former president’s book The Art of the Deal as a metaphor for market strategy.
"Think Big": Trump’s philosophy of bold ambition is tied to Goldman's emphasis on the "Magnificent 7" — major tech companies such as Apple, Amazon, and Tesla. While these companies are projected to outperform, Goldman expects their margin of outperformance to narrow, suggesting a focus on broader opportunities in mid-cap and smaller growth stocks.